Pham, Nathan H.
Bena, James
Bhatt, Deepak L.
Kennedy, Laurence
Schauer, Philip R.
Kashyap, Sangeeta R.
Funding for this research was provided by:
Ethicon Endo-Surgery (EES IIS 19900)
American Diabetes Association (1-11-26 CT)
National Institutes of Health (R01-DK089547)
Article History
First Online: 15 November 2017
Compliance with Ethical Standards
:
: Nathan Pham reports receiving consulting fees from FundRx; Dr. Bhatt discloses the following relationships - Advisory Board: Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, Regado Biosciences; Board of Directors: Boston VA Research Institute, Society of Cardiovascular Patient Care; Chair: American Heart Association Quality Oversight Committee; Data Monitoring Committees: Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (Chief Medical Editor, Cardiology Today’s Intervention), Society of Cardiovascular Patient Care (Secretary/Treasurer), WebMD (CME steering committees); Other: Clinical Cardiology (Deputy Editor), NCDR-ACTION Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair); Research Funding: Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, The Medicines Company; Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease); Site Co-Investigator: Biotronik, Boston Scientific, St. Jude Medical (now Abbott); Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, PLx Pharma, Takeda; Dr. Schauer reports receiving consulting fees from Ethicon and Novo Nordisk, lecture fees from Ethicon, Eli Lilly, Nestle, and Global Academy for Medical Education, fees for board membership and stock options or equity from Surgiquest, Barosense, RemedyMD, and SE Healthcare Quality Consulting, fees for providing expert testimony from Physicians Reviews of Surgery regarding complications of surgery, and financial support for a fellowship program from Stryker and having a pending patent application with the Cleveland Clinic regarding medical devices for weight loss; Dr. Kashyap reports receiving consulting fees from Ethicon. James Bena and Dr. Kennedy report no other potential conflict of interest relevant to this article.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.